Neurones (France) Performance

NRO Stock  EUR 35.55  1.05  3.04%   
The company secures a Beta (Market Risk) of 0.0436, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Neurones' returns are expected to increase less than the market. However, during the bear market, the loss of holding Neurones is expected to be smaller as well. At this point, Neurones has a negative expected return of -0.27%. Please make sure to verify Neurones' rate of daily change, and the relationship between the kurtosis and market facilitation index , to decide if Neurones performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Neurones has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Forward Dividend Yield
0.0377
Payout Ratio
0.625
Forward Dividend Rate
1.3
Ex Dividend Date
2025-06-11
1
Private companies are Neurones S.A.s biggest owners and were hit after market cap dropped 47m - simplywall.st
12/22/2025
2
NEURONES 5.1 percent organic growth in 2025 - The Manila Times
02/11/2026
Begin Period Cash Flow295.4 M
Total Cashflows From Investing Activities-19.7 M
  

Neurones Relative Risk vs. Return Landscape

If you would invest  4,250  in Neurones on November 20, 2025 and sell it today you would lose (695.00) from holding Neurones or give up 16.35% of portfolio value over 90 days. Neurones is producing return of less than zero assuming 1.6492% volatility of returns over the 90 days investment horizon. Simply put, 14% of all stocks have less volatile historical return distribution than Neurones, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Neurones is expected to under-perform the market. In addition to that, the company is 2.2 times more volatile than its market benchmark. It trades about -0.17 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.19 per unit of volatility.

Neurones Target Price Odds to finish over Current Price

The tendency of Neurones Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 35.55 90 days 35.55 
close to 99
Based on a normal probability distribution, the odds of Neurones to move above the current price in 90 days from now is close to 99 (This Neurones probability density function shows the probability of Neurones Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Neurones has a beta of 0.0436. This indicates as returns on the market go up, Neurones average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Neurones will be expected to be much smaller as well. Additionally Neurones has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Neurones Price Density   
       Price  

Predictive Modules for Neurones

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neurones. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
33.0334.6436.25
Details
Intrinsic
Valuation
LowRealHigh
28.2529.8639.10
Details
Naive
Forecast
LowNextHigh
31.7433.3434.95
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.540.540.54
Details

Neurones Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Neurones is not an exception. The market had few large corrections towards the Neurones' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Neurones, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Neurones within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.26
β
Beta against Dow Jones0.04
σ
Overall volatility
2.49
Ir
Information ratio -0.18

Neurones Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Neurones for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Neurones can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Neurones generated a negative expected return over the last 90 days
About 70.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: NEURONES 5.1 percent organic growth in 2025 - The Manila Times

Neurones Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Neurones Stock often depends not only on the future outlook of the current and potential Neurones' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neurones' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding24.3 M
Cash And Short Term Investments326.5 M

Neurones Fundamentals Growth

Neurones Stock prices reflect investors' perceptions of the future prospects and financial health of Neurones, and Neurones fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neurones Stock performance.

About Neurones Performance

By analyzing Neurones' fundamental ratios, stakeholders can gain valuable insights into Neurones' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Neurones has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Neurones has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 0.27  0.25 
Return On Tangible Assets 0.09  0.08 
Return On Capital Employed 0.15  0.13 
Return On Assets 0.07  0.05 
Return On Equity 0.12  0.09 

Things to note about Neurones performance evaluation

Checking the ongoing alerts about Neurones for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neurones help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Neurones generated a negative expected return over the last 90 days
About 70.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: NEURONES 5.1 percent organic growth in 2025 - The Manila Times
Evaluating Neurones' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Neurones' stock performance include:
  • Analyzing Neurones' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neurones' stock is overvalued or undervalued compared to its peers.
  • Examining Neurones' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Neurones' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neurones' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Neurones' stock. These opinions can provide insight into Neurones' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Neurones' stock performance is not an exact science, and many factors can impact Neurones' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Neurones Stock analysis

When running Neurones' price analysis, check to measure Neurones' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurones is operating at the current time. Most of Neurones' value examination focuses on studying past and present price action to predict the probability of Neurones' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurones' price. Additionally, you may evaluate how the addition of Neurones to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios